EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Evaluation of 2 phenanthrenemethanols for anti malarial activity in man wr 122455 and wr 171669



Evaluation of 2 phenanthrenemethanols for anti malarial activity in man wr 122455 and wr 171669



American Journal of Tropical Medicine and Hygiene 25(6): 769-774



Two phenanthrenemethanols, WR 122,455 [.alpha.-(2-piperidyl-3,6-bis(trifluoromethyl)-9-phenanthrene methanol hydrochloride] and WR 171,669 [1-(1,3-dichloro-6-trifluoromethyl-9-phenanthryl)-3 di(n-butyl) amino propanol hydrochloride] were tested in man for oral tolerance, toxicity and efficacy against Plasmodium falciparum. In healthy subjects, gastrointestinal symptoms limited single-day dosage of WR 122,455 to 800 mg and WR 171,669 to 1260 mg. No laboratory abnormalities, phototoxicity or gastrointestinal blood loss were noted in the subjects receiving these drugs. In subjects infected with malaria, WR 122,455 cleared parasitemia when given for 1 day in doses from 440 to 880 mg; recrudescences occurred in these subjects who were infected with either chloroquine-sensitive or chloroquine-resistant P. falciparum. WR 122,455 at 480 mg/day for 3-6 days cured 9/9 cases of chloroquine-resistant and 4/4 cases of chloroquine-sensitive P. falciparum infection. WR 171,669 at 1 g/day for 3 days cured 6/6 subjects with chloroquine-resistant and 3/3 cases of chloroquine-sensitive infection. Both agents cleared parasitemia and fever promptly.

(PDF emailed within 1 workday: $29.90)

Accession: 005394684

Download citation: RISBibTeXText



Related references

The chemo therapy of rodent malaria part 25 anti malarial activity of wr 122455 a 9 phenanthrenemethanol in vivo and in vitro. Annals of Tropical Medicine and Parasitology 70(3): 259-270, 1976

Cardio pulmonary effects of anti malarial drugs part 2 phenanthrenemethanols. Toxicology and Applied Pharmacology 17(1): 118-129, 1970

Excretion of 3 anti malarial drugs wr 38839 wr 33063 and wr 122455 in rhesus monkeys with chronic biliary cannulae. Toxicology & Applied Pharmacology 22(2): 291, 1972

Subacute toxicity of the new anti malarial agent bis tri fluoromethyl alpha 2 piperidyl 9 phenanthrene methanol hydro chloride wr 122455 in beagles. Federation Proceedings 30(2): 444, 1971

Metal-chloroquine derivatives as possible anti-malarial drugs: evaluation of anti-malarial activity and mode of action. Malaria Journal 13(): 471-471, 2015

Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds. Malaria Journal 13(): 2-2, 2014

Evaluation of two phenanthrenemethanols for antimalarial activity in man: WR 122,455 and WR 171,669. American Journal of Tropical Medicine and Hygiene 25(6): 769-774, 1976

In vitro evaluation of the anti-gonococcal activity of eleven anti-malarial compounds and three macrolides with proposed interpretative criteria for N gonorrhoeae susceptibility testing. Abstracts of the General Meeting of the American Society for Microbiology 95(0): 19, 1995

Evaluation of bioluminescence-based assays of anti-malarial drug activity. Malaria Journal 12(): 58-58, 2013

Evaluation of the anti-malarial activity and cytotoxicity of 2,4-diamino-pyrimidine-based kinase inhibitors. European Journal of Medicinal Chemistry 124(): 896-905, 2016

Anti-malarial, anti-algal, anti-tubercular, anti-bacterial, anti-photosynthetic, and anti-fouling activity of diterpene and diterpene isonitriles from the tropical marine sponge Cymbastela hooperi. Organic & Biomolecular Chemistry 9(2): 400-407, 2011

Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model. Malaria Journal 14(): 505-505, 2016

Diversity-oriented synthesis and activity evaluation of substituted bicyclic lactams as anti-malarial against Plasmodium falciparum. Malaria Journal 13(): 467-467, 2015

Potent in vivo anti-malarial activity and representative snapshot pharmacokinetic evaluation of artemisinin-quinoline hybrids. Malaria Journal 12: 71-71, 2013

In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays. Malaria Journal 8(): 79-79, 2009